<- Go home

Added to YB: 2025-11-18

Pitch date: 2025-11-14

TEM [neutral]

Tempus AI, Inc.

-30.37%

current return

Author Info

No bio for this author

Company Info

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.

Market Cap

$8.4B

Pitch Price

$67.93

Price Target

N/A

Dividend

N/A

EV/EBITDA

-57.12

P/E

-33.40

EV/Sales

7.05

Sector

Life Sciences Tools and Services

Category

growth

Show full summary:
TEM | Tempus AI Q3 2025 Financial Report Highlights

TEM (earnings): Rev +85% to $334M, first positive adj EBITDA $1.5M (vs $4M est), Q4 guidance $20M EBITDA. Genomics +117%, Insights bookings +38%. Gross margin 63.6% (+400bps). Acquired Paige for multimodal AI, 3 FDA approvals. At $68 vs DCF $55-65, overvalued despite strong execution.

Read full article (9 min)